Variation in the 5′-flanking region of the neuropeptide Y2 receptor gene and metabolic parameters

Metabolism: Clinical and Experimental

Volumn 59, Issue 11, 2010, Pages 1591-1596

  Takiguchi, Etsuko ^a   Fukano, Chika ^a   Kimura, Yukari ^a   Tanaka, Masayo ^a   Tanida, Keiko ^a   Kaji, Hidesuke ^a  

^a UNIVERSITY OF HYOGO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUROPEPTIDE Y2 RECEPTOR; TRIACYLGLYCEROL; NEUROPEPTIDE Y RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DNA FLANKING REGION; FEMALE; GENE LOCATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECEPTOR GENE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; MORPHOMETRICS;

5' FLANKING REGION; ADULT; AGED; BODY WEIGHTS AND MEASURES; CHOLESTEROL, HDL; FEMALE; GENOTYPE; HUMANS; MALE; METABOLISM; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NEUROPEPTIDE Y; SEX FACTORS; TRIGLYCERIDES;

EID: 78049235990     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.02.014     Document Type: Article

References (32)

1. Björntorp P. Metabolic implication of body fat distribution Diabetes Care 14 1991 1132 1143
2. Fryan K.N. Visceral fat and insulin resistance: causative or correlative? Br J Nutr 83 2000 71 77
3. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 2000 697 738
4. Matuzawa Y., Funakoshi T., and Nakamura T. Molecular mechanism of metabolic syndrome X: contributors of adipocytokine, adipocyte-derived bioactive substances Ann N Y Acad Sci 892 1999 146 154
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
6. Examination Committee of Criteria for the Metabolic Syndrome in Japan Definition and diagnosis criteria of metabolic syndrome J Jpn Soc Intern Med (in Japanese) 94 2005 794 809
7. Alberti K.G., Zimmet P., Shaw J. Epidemiology Task Force Consensus Group The metabolic syndrome-a new world-wide definition Lancet 366 2005 1059 1062
8. Kahn R., Ferrannini E., Buse J., and Stern M. The metabolic syndrome: time for a critical appraisal Diabetes Care 28 2005 2289 2304
9. Kissebah A.H., Sonnenberg G.E., Myklebust J., Goldstein M., Broman K., and James R.G. Quantitative trait loci on chromosome 3 and 17 influence phenotypes of the metabolic syndrome Proc Natl Acad Sci U S A 97 2000 14478 14483
10. McCarthy J.J., Meyer J., Moliterno D.J., Newby L.K., Rogers W.J., and Topol E.J. Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients Hum Genet 114 2003 87 98
11. Lopes C., Diana C., Durand E., and Froguel P. PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population Diabetologia 46 2003 1284 1290
12. Shin H.D., Park B.L., Kim L.H., Jung H.S., Cho Y.M., and Moon M.K. Genetic polymorphisms in peroxisome proliferator-activated receptor γ associated with obesity Diabetes 53 2004 847 851
13. Weng S.W., Liou C.W., Lin T.K., Wei Y.H., Lee C.F., and Eng H.O.L. Association of mitochondrial deoxyribonucleic acid 16189 variant (T→C transition) with metabolic syndrome in Chinese adults J Clin Endocrinol Metab 90 2005 5037 5040
14. Sutton B.S., Weinert S., Langefeld C.D., Williams A.H., Campbell J.K., and Saad M.F. Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS family study Hum Genet 117 2005 107 118
15. Baessler A., Hasinoff M.J., Fisher M., Reinhard W., Sonnenberg G.E., and Olivier M. Genetic linkage and association of the growth hormone secretagogue receptor (ghrelin receptor) gene in human obesity Diabetes 54 2005 259 267
16. Kaji H., Fukano C., Kimura Y., Takiguchi E., and Tanida K. Genetic variations at the CCAAT/ enhancer-binding protein δ are associated with metabolic phenotypes in the Japanese population Metab Synd Relat Disord 6 2008 24 31
17. Masuzaki H., Paterson J.M., Shinyama H., Morton N.M., Mullins J.J., and Seckl J.R. A transgenic model of visceral obesity and the metabolic syndrome Science 294 2001 2166 2170
18. Morton N.M., Paterson J.M., Masuzaki H., Holmes M.C., Staels B., and Fievet C. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11β-hydroxysteroid dehydrogenase type 1-deficient mice Diabetes 53 2004 931 938
19. Kuo L.E., Kitlinska J.B., Tilan J.U., Li L., Baker S.B., and Johnson M.D. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome Nat Med 13 2007 803 811
20. Schwartz M.W., Porte D. Jr, Seeley R.J., and Baskin D.G. Central nervous system control of food intake Nature 404 2000 661 671
21. McMinn J.E., Baskin D.G., and Schwarz M.W. Neuroendocrine mechanisms regulating food intake and body weight Obes Rev 1 2000 37 46
22. Broberger C. Brain regulation of food intake and appetite: molecules and networks J Intern Med 258 2005 301 327
23. Karvonen M.K., Pesonen U., Koulu M., Niskanen L., Laakso M., and Rissanen A. Association of a leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels Nat Med 4 1998 1434 1437
24. Karvonen M.K., Koulu M., Pesonen U., Uusitupa M.I., Tammi A., and Viikari J. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children J Clin Endocrinol Metab 85 2000 1455 1460
25. Niskanen L., Karvonen M.K., Valve R., Koulu M., Pesonen U., and Mercuri M. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects J Clin Endocrinol Metab 85 2000 2266 2269
26. Hung C.C., Pirie F., Luan J., Lank E., Motala A., and Yeo G.S. Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits Diabetes 53 2004 2461 2466
27. Lavebratt C., Alpman A., Persson B., Arner P., and Hoffstedt J. Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men Int J Obes 30 2006 453 459
28. Campbell C.D., Lyon H.N., Nemesh J., Drake J.A., Tuomi T., and Gaudet D. Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men Diabetes 56 2007 1460 1467
29. Siddiq A., Gueorguiev M., Samson C., Hercberg S., Heude B., and Levy-Marchal C. Single nucleotide polymorphisms in the neuropeptide Y2 receptor (NPY2R) gene and association with severe obesity in French white subjects Diabetologia 50 2007 574 584
30. Torekov S.S., Larsen L.H., Andersen G., Albrechtsen A., Glümer C., and Borch-Johnsen K. Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects Diabetologia 49 2006 2653 2658
31. Blumenthal J.B., Andersen R.E., Mitchell B.D., Seibert M.J., Yang H., and Herzog H. Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels Clin Genet 62 2002 196 202
32. Erkkilä A.T., Lindi V., Lehto S., Laakso M., and Uusitupa M.I. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease Mol Genet Metab 75 2002 260 264